IL-1 alpha

IL-1 alpha 詳細

英語名Interleukin-1 alpha市販薬剤の数1
治験薬の数11ターゲットの別称Interleukin-1 Alpha,IL1A,IL1F1,IL-1 alpha,Interleukin 1 Alpha,Hematopoietin-1,Pro-Interleukin-1-Alpha,Preinterleukin 1 Alpha,IL1-ALPHA,IL-1A,IL1,Interleukin-1alpha
研究&開発段階Approved
英語名Interleukin-1 alpha
ターゲットの別称Interleukin-1 Alpha,IL1A,IL1F1,IL-1 alpha,Interleukin 1 Alpha,Hematopoietin-1,Pro-Interleukin-1-Alpha,Preinterleukin 1 Alpha,IL1-ALPHA,IL-1A,IL1,Interleukin-1alpha
市販薬剤の数1
治験薬の数11
研究&開発段階Approved

IL-1 alpha 製品リスト

  • 属性

    Protein (4)

  • 製品ライブラリ

    オンライン (4)

  • Human (2)Mouse (2)

  • タグ

    His Tag (2)His Tag & Avi Tag (2)

  • マーカー

    Unconjugated (2)Biotin-labeled (2)

IL-1 alphaバックグランド

Interleukin-1 alpha (IL1a) is also known as IL-1A, IL1, IL1-ALPHA,IL1F1,and is a cytokine of the interleukin-1 family. IL1a possesses a wide spectrum of metabolic, physiological, haematopoietic activities, and plays one of the central roles in the regulation of the immune responses. It binds to the interleukin-1 receptor. IL-1α is constitutively produced by epithelial cells. It is found in substantial amounts in normal human epidermis and is distributed in a 1:1 ratio between living epidermal cells and stratum corneum.The constitutive production of large amounts of IL-1α precursor by healthy epidermal keratinocytes interfere with the important role of IL-1α in immune responses, assuming skin as a barrier, which prevents the entry of pathogenic microorganisms into the body. In vitro, IL-1α possesses biological effect on cells in the picomolar to femtomolar range. In vivo, Shortly after an onset of an infection into organism, IL-1α activates a set of immune system response processes.

IL-1 alpha分子の別称

IL1A,IL-1 ALPHA,IL1F1,IL1α

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Tadekinig alfar-hIL-18BP; IL-18BPPhase 3 ClinicalAb2 Bio LtdAutoimmune Lymphoproliferative Syndrome; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome
詳細
LutikizumabABT-981Phase 3 ClinicalAbbvie IncColitis, Ulcerative; Crohn Disease; Dermatitis, Atopic; Hidradenitis Suppurativa; Osteoarthritis; Osteoarthritis, Knee
詳細
KPL-387KPL-387Phase 3 ClinicalKiniksa Pharmaceuticals LtdHeart Diseases; Pericarditis
詳細
BermekimabT2-18C3; RA-18C3; CV-18C3; CA-18C3; MABP-1; MABp1; JNJ-77474462; MAB-p1Phase 2 ClinicalXbiotech IncAcne Vulgaris; Colorectal Neoplasms; Dermatitis, Atopic; Diabetes Mellitus, Type 2; Digestive System Diseases; Eczema; Hematologic Neoplasms; Hidradenitis Suppurativa; Neoplasms; Psoriasis; Pyoderma Gangrenosum; Scleroderma, Systemic
詳細
ABBV-9832ABBV-9832Phase 2 ClinicalAbbvie IncArthritis, Rheumatoid
詳細
ABBV-166ABBV-166Phase 2 ClinicalAbbvie IncArthritis, Psoriatic; Crohn Disease
詳細
AC-701AC-701Phase 2 ClinicalTwi Pharmaceuticals IncExanthema; Rosacea
詳細
VilamakitugXB-2001Phase 2 ClinicalXbiotech IncArthritis, Rheumatoid; Axial Spondyloarthritis; Pancreatic Neoplasms; Rheumatic Diseases
詳細
CAN-10CAN-10Phase 1 ClinicalLund University FoundationMyocarditis; Plaque psoriasis; Scleroderma, Systemic
詳細
GenSci-161GenSci-161Phase 1 ClinicalChangchun GeneScience Pharmaceuticals Co LtdEndometriosis; Hidradenitis Suppurativa
詳細
Interleukin-1-alpha targeting antibody (XBiotech)Phase 1 ClinicalXbiotech Inc
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
RilonaceptKPL-914; RGN-303ApprovedRegeneron Pharmaceuticals IncArcalyst, 炎朵United StatesCryopyrin-Associated Periodic SyndromesKiniksa Pharmaceuticals Ltd2008-02-27Anemia; Arthritis, Juvenile; Atherosclerosis; Coronary Artery Disease; Cryopyrin-Associated Periodic Syndromes; Deficiency of interleukin-1 receptor antagonist; Diabetes Mellitus, Type 1; Familial Mediterranean Fever; Genetic Diseases, Inborn; Gout; Hearing Loss, Sensorineural; Inflammation; Muckle-Wells Syndrome (MWS); Pericarditis; Renal Insufficiency, Chronic; Sarcoidosis; Schnitzler Syndrome; Scleroderma, Diffuse; Scleroderma, Systemic; Still's Disease, Adult-Onset; Urticaria; Vascular Diseases
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8